专题:Metabolism, Diabetes, and Cancer

This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
最新文献
近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

article Full Text OpenAlex 2388 FWCI436.6362

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

article Full Text OpenAlex 1382 FWCI446.7241

The hallmarks of cancer metabolism: Still emerging

review Full Text OpenAlex 1326 FWCI118.2875

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

review Full Text OpenAlex 948 FWCI114.5665

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

review Full Text OpenAlex 943 FWCI119.8266

New insights into activation and function of the AMPK

review Full Text OpenAlex 904 FWCI68.3822

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

article Full Text OpenAlex 845 FWCI97.9686

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 792 FWCI117.7143

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 750 FWCI62.2287

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

article Full Text OpenAlex 742 FWCI87.3061